Wednesday, February 18, 2009

Building Biotech - The Science of Doing International Business

Jeff Morhet, Chairman and CEO of InNexus Biotechnology is speaking on "Building Biotech: The Science of Doing International Business" at AZIGG on March 2nd, 7:30am at headquarters in Phoenix. Please RSVP here:
InNexus (Toronto Stock Exchange IXS.V) is headquartered in British Columbia with principal management based in Scottsdale at the campus of Mayo Clinic. InNexus has its own in-house drug developmental facilities that validate protein and peptide discoveries, enabling InNexus and its strategic partners to advance novel drug therapeutics and diagnostics.

AZIGG Presents:
Jeff Morhet, Chairman, CEO and President
InNexus Biotechnology, Inc.
"Building Biotech: The Science of Doing International Business"
Monday, March 2nd, 7:30am - 9:00am

Location: Headquarters of, 4747 N 22nd Street

(South of Camelback on the east side of 22nd, free parking)
Investment $10 includes coffee, water and juice
Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet. Jeff Morhet
Jeff Morhet will be sharing international insights from his vast global experience in the pharmaceutical/biotechnology industry. He has launched multiple companies and is highly experienced in the areas of investor relations and corporated finance, participating in raising over $100 million in public offerings, venture capital, equities and mergers. Jeff has also founded the life science organizations THIRDBIOTECH and ThirdBioTech Research Group. Please RSVP:

Arizona Internet Marketing
Arizona Biotechnology Marketing
Biotechnology News


Post a Comment

Links to this post:

Create a Link

<< Home